10x Genomics, Inc. financial data

Symbol
TXG on Nasdaq
Industry
Laboratory Analytical Instruments
Location
6230 Stoneridge Mall Road, Pleasanton, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 499 % -6.62%
Quick Ratio 72.5 % -1.68%
Debt-to-equity 29.2 % +10.1%
Return On Equity -25.1 % +11.5%
Return On Assets -19.4 % +13.4%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 119M shares +3.39%
Entity Public Float 5.7B USD +26.7%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 121M shares +2.55%
Weighted Average Number of Shares Outstanding, Diluted 121M shares +2.55%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 630M USD +6.56%
Cost of Revenue 210M USD +18.2%
Operating Income (Loss) -200M USD +14.3%
Nonoperating Income (Expense) 24M USD +63.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -176M USD +19.5%
Income Tax Expense (Benefit) 6.63M USD +38.6%
Net Income (Loss) Attributable to Parent -183M USD +18.3%
Earnings Per Share, Basic -1.54 USD/shares +18.9%
Earnings Per Share, Diluted -1.54 USD/shares +18.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 359M USD +63.5%
Accounts Receivable, after Allowance for Credit Loss, Current 83.5M USD -19.6%
Inventory, Net 94.1M USD +16.2%
Assets, Current 594M USD +5.61%
Property, Plant and Equipment, Net 259M USD -9.21%
Operating Lease, Right-of-Use Asset 59.6M USD -13.9%
Intangible Assets, Net (Excluding Goodwill) 16.1M USD -26%
Goodwill 4.51M USD 0%
Other Assets, Noncurrent 4.9M USD +83.4%
Assets 938M USD -1.13%
Accounts Payable, Current 26.2M USD +39.1%
Employee-related Liabilities, Current 30.1M USD +5.63%
Contract with Customer, Liability, Current 17.8M USD +59.4%
Liabilities, Current 121M USD +15.8%
Contract with Customer, Liability, Noncurrent 12.3M USD
Operating Lease, Liability, Noncurrent 76.5M USD -13.6%
Other Liabilities, Noncurrent 4.95M USD -51.2%
Liabilities 215M USD +5.74%
Accumulated Other Comprehensive Income (Loss), Net of Tax 32K USD
Retained Earnings (Accumulated Deficit) -1.42B USD -14.8%
Stockholders' Equity Attributable to Parent 723M USD -3.01%
Liabilities and Equity 938M USD -1.13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.7M USD -281%
Net Cash Provided by (Used in) Financing Activities 1.64M USD
Net Cash Provided by (Used in) Investing Activities 10.6M USD -91.1%
Common Stock, Shares Authorized 1.1B shares 0%
Common Stock, Shares, Issued 119M shares +3.39%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.5M USD -103%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 398M USD +26.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 443M USD +21.6%
Deferred Tax Assets, Gross 460M USD +20.3%
Operating Lease, Liability 85.9M USD -12.8%
Payments to Acquire Property, Plant, and Equipment 2.91M USD -36.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -182M USD +16.8%
Lessee, Operating Lease, Liability, to be Paid 106M USD -14.5%
Property, Plant and Equipment, Gross 383M USD +1.19%
Operating Lease, Liability, Current 9.42M USD -5.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.5M USD -0.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.9M USD -10.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19.9M USD -21.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.7M USD -4.21%
Deferred Tax Assets, Operating Loss Carryforwards 167M USD -4.81%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 45.7M USD +44%
Lessee, Operating Lease, Liability, to be Paid, Year Four 15.9M USD +1.32%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 9.19M USD +41.8%
Deferred Tax Assets, Net of Valuation Allowance 17.4M USD -5.8%
Share-based Payment Arrangement, Expense 147M USD -12.8%
Interest Expense 15K USD -95.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%